Chronic Hepatitis C (CHC) - Genotype 3 Infection in Canada
NCT01100749 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 25
Last updated 2015-05-28
Summary
Hepatitis C is a small RNA virus spread by blood to blood contamination. There are to date 6 known genotypes and within each there are several subtypes. Although all genotypes are distributed worldwide some are more common in certain countries and/or among certain populations.
Conditions
- Chronic Hepatitis C - Genotype 3
Sponsors & Collaborators
-
University Health Network, Toronto
lead OTHER
Principal Investigators
-
Dr. E.J. Heathcote, MD, FRCP, FRCP(C) · University Health Network - Toronto Western Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-02-28
- Primary Completion
- 2013-06-30
- Completion
- 2013-06-30
Countries
- Canada
Study Locations
More Related Trials
-
Scaling Up Point-of-Care Hepatitis C Testing and Treatment in Canada
NCT07095192 ·Status: RECRUITING
-
Associations, Outcomes and Genomics of GB Virus C, Hepatitis C Virus and Human Immunodeficiency Virus Infection
NCT00164060 ·Status: TERMINATED
-
The Effect of HIV Tat Protein on HCV Replication in an In-vitro Model System
NCT01206933 ·Status: COMPLETED
-
Cellular Immune Responses in the Liver in Chronic Hepatitis C (CHC) Patients
NCT01062659 ·Status: WITHDRAWN
-
Hepatitis C Virus and the Humoral Immune System
NCT00219999 ·Status: COMPLETED
-
A Study on the Correlation Between Interleukin 28B Genotypes With Clinical and Demographic Characteristics in Treatment-Naïve and Treatment-Experienced Patients With Chronic Hepatitis C
NCT01675427 ·Status: COMPLETED ·Phase: PHASE4
-
HCV (Hepatitis C Virus) Viral and Host Genotyping (IL28B, Interleukin 28B) in China
NCT01293279 ·Status: COMPLETED
-
Clinical Performance of Abbott RealTime Hepatitis C Virus (HCV) Genotype II Test
NCT00979979 ·Status: COMPLETED
-
Eliminating Hepatitis C Transmission by Enhancing Care and Treatment Among HIV Co-infected Individuals
NCT02786758 ·Status: COMPLETED
-
A Phase 1/2 Study of CF102 in Patients With Chronic Hepatitis C Genotype 1
NCT00790673 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Evaluation of Multiple HCV Diagnosis Pathways for Efficacy, Cost Effectiveness and Cure in NHS Tayside
NCT03513796 ·Status: COMPLETED
-
Immune Response to Hepatitis C Virus
NCT00165919 ·Status: WITHDRAWN
-
The National Australian HCV Point-of-Care Testing Program - HCV Antibody Testing Minimal Dataset
NCT05713136 ·Status: RECRUITING
-
Identification of Viral Variants Involved in the Transmission of Hepatitis C and Characterization of Antigenic and Functional Properties of Their Envelope Glycoproteins
NCT02574884 ·Status: COMPLETED ·Phase: NA
-
HCV Genotype 1a Shows a Better Virological Response to Antiviral Therapy Than HCV Genotype 1b
NCT01342003 ·Status: COMPLETED
-
The Natural History and Treatment of Acute Hepatitis C Virus (HCV) in HIV-positive Individuals
NCT01289652 ·Status: UNKNOWN
-
HCV RNA Fingerstick Assay as Useful Point of Care of Diagnostic Tool for Drug Users in Brussels
NCT04610762 ·Status: COMPLETED
-
Surveillance for Antiviral Resistant Variants in Chronic Hepatitis C Patients
NCT02065999 ·Status: COMPLETED
-
EXtended Therapy in Hepatitis C Genotype 3 Infected Patients
NCT01095445 ·Status: TERMINATED ·Phase: PHASE3
-
Comparison of OraQuick HCV Rapid Antibody Test and Standard Serologic Screening for Hepatitis C: Validity, Acceptability and Impact on Linkage to Care
NCT02084719 ·Status: TERMINATED ·Phase: NA
-
Study on Immunopathogenesis in HIV and Hepatitis C Coinfection
NCT01296529 ·Status: COMPLETED
-
Leukapheresis for Research on HCV-Coinfected Patients
NCT00076427 ·Status: COMPLETED
-
Qualification of Point-of-Care Assays for Management of HCV Patients
NCT02335320 ·Status: UNKNOWN
-
Control and Elimination Within Australia of Hepatitis C From People Living With HIV
NCT02102451 ·Status: UNKNOWN
-
Study of Hepatic Responses in Patients Receiving Direct-acting Anti-HCV Drugs
NCT02532907 ·Status: COMPLETED